The table below shows Inhibrx, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Q1 2020
Operating cash flow
-$63.05M
-$39.94M
-$26.94M
-$21.65M
-$7.39M
Capital expenditure
$1.12M
$23.00K
$117.00K
$14.00K
$91.00K
Investing cash flow
-$1.12M
-$23.00K
-$117.00K
-$14.00K
-$91.00K
Dividends paid
-
-
-
-
-
Stock buybacks
-
INBX operating cash flow (10-K history)
Inhibrx, Inc. reported operating cash flow of -$193.31M for fiscal year 2023. That is down 67.7% from -$115.30M in fiscal 2022. Over the 5 fiscal years shown, operating cash flow declined from -$32.08M (FY 2019) to -$193.31M. Figures come from the company's audited annual reports as filed with the SEC.